Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolism
复制标题
首次无端静脉血栓栓塞患者中 JAK2 V617F 突变发生率较低
DOI：
--
复制
发表时间：
2011
影响因子：
6.5
通讯作者：
M. Kovacs
中科院分区：
文献类型：
--
作者：
M. Rodger;N. Kekre;G. Le Gal;S. Kahn;P. Wells;D. Anderson;I. Chagnon;S. Solymoss;M. Crowther;A. Perrier;R. White;L. Vickars;T. Ramsay;M. Betancourt;M. Kovacs
Bladé，J.，Samson，D.，Reess，D.，Apperley，J.，Björkstrand，B.，Gahrton，G.，Gertz，M.，Giralt，S.，Jagannath，S.&Vesole，D.(1998)评估接受高剂量治疗和造血干细胞移植治疗的多发性骨髓瘤患者的疾病反应和进展的标准。EBMT骨髓瘤小组委员会。欧洲血液和骨髓移植组织。《英国血液学杂志》，102,1115-1123。霍尔，S.L.，Tate，J.，Gill，D.和Mollee，P.(2009)多发性骨髓瘤患者自体干细胞移植后异常蛋白条带的意义。临床生物化学家。评论，30,113-118。Hovenga，S.，de Wolf，J.T.，Guikema，J.E.，Klip，H.，Smit，J.W.，Smit Sibinga，C.T.，Bos，N.A.和Vellenga，E.(2000)VAD和EDAP课程后多发性骨髓瘤的自体干细胞移植：移植后寡克隆血清免疫球蛋白的高发生率。骨髓移植，25,723-728。Kim，H.，Sohn，H.J.，Kim，S.，Lee，J.S.，Kim，W.K.&Suh，C.(2006)早期淋巴细胞恢复预示着多发性骨髓瘤的自体外周血干细胞移植后存活时间更长。骨髓移植，37,1037-1042。Larrea，C.F.，Trovar，N.，Cibeira，M.T.，Arostegui，JI.，Rosinol，L.，Elena，M.，Filella，X.，Yague，J.&Blade，J.(2011)诱导化疗后完全缓解的多发性骨髓瘤患者出现寡克隆条带：与新药的使用有关。血液病，96,171-173。Rasmussen，T.，Lodahl，M.，Hancke，S.&Johnsen，H.H.(2004)在多发性骨髓瘤克隆型中，CD19+/CD27+记忆B细胞在骨髓、外周血和淋巴结中循环。白血病和淋巴瘤，45,1413-1417。Szczepek，A.J.，Seeberger，K.，Wizniak，J.，Mant，M.J.，Belch，A.R.和Pilarski，L.M.(1998)通过单细胞和原位逆转录聚合酶链式反应，多发性骨髓瘤中循环中的高频率B细胞与自体骨髓浆细胞共享克隆型Ig重链VDJ重排。血液，92,2844-2855。Terpos，E.，Szydlo，R.，Apperley，J.F.，Hatjiharissi，E.，Politou，M.，Meletis，J.，Viniou，N.，Yataganas，X.，Goldman，J.&Rahemtulla，A.(2003)可溶性受体激活剂核因子kappaB配体-骨保护素比率预测多发性骨髓瘤的存活率：建议一种新的预后指数。血液，102,1064-1069。Zent，C.S.，Wilson，C.S.，Tricot，G.，Jagannath，S.，Siegel，D.，Desikan，K.R.，Munshi，N.，Bracy，D.，Barlogie，B.&Butch，A.W.(1998)大剂量治疗和造血细胞移植治疗多发性骨髓瘤中的寡克隆蛋白条带和Ig同型转换。血液，91,3518-3523。
Bladé, J., Samson, D., Reece, D., Apperley, J., Björkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S. & Vesole, D. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by highdose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. British Journal of Haematology, 102, 1115–1123. Hall, S.L., Tate, J., Gill, D. & Mollee, P. (2009) Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation. The Clinical Biochemist. Reviews, 30, 113–118. Hovenga, S., de Wolf, J.T., Guikema, J.E., Klip, H., Smit, J.W., Smit Sibinga, C.T., Bos, N.A. & Vellenga, E. (2000) Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplantation, 25, 723–728. Kim, H., Sohn, H.J., Kim, S., Lee, J.S., Kim, W.K. & Suh, C. (2006) Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplantation, 37, 1037–1042. Larrea, C.F., Trovar, N., Cibeira, M.T., Arostegui, J.I., Rosinol, L., Elena, M., Filella, X., Yague, J. & Blade, J. (2011) Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of noval agents. Haematologica, 96, 171–173. Rasmussen, T., Lodahl, M., Hancke, S. & Johnsen, H.E. (2004) In multiple myeloma clonotypic CD38)/CD19+/CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. Leukaemia and Lymphoma, 45, 1413–1417. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. & Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood, 92, 2844–2855. Terpos, E., Szydlo, R., Apperley, J.F., Hatjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J. & Rahemtulla, A. (2003) Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood, 102, 1064–1069. Zent, C.S., Wilson, C.S., Tricot, G., Jagannath, S., Siegel, D., Desikan, K.R., Munshi, N., Bracy, D., Barlogie, B. & Butch, A.W. (1998) Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood, 91, 3518–3523.
影响因子：
20.3
作者：
Xu, Xuesong;Zhang, Qi;Zhao, Zhizhuang Joe
通讯作者：
Zhao, Zhizhuang Joe